-
公开(公告)号:US20120142714A1
公开(公告)日:2012-06-07
申请号:US13306069
申请日:2011-11-29
申请人: TSUNEO YASUMA , MAKOTO KAMATA , TOHRU YAMASHITA , HIDEKI HIROSE , MASATAKA MURAKAMI , ASATO KINA , KAZUKO YONEMORI , RYO MIZOJIRI , IKUO FUJIMORI , TAKUYA FUJIMOTO , ZENICHI IKEDA
发明人: TSUNEO YASUMA , MAKOTO KAMATA , TOHRU YAMASHITA , HIDEKI HIROSE , MASATAKA MURAKAMI , ASATO KINA , KAZUKO YONEMORI , RYO MIZOJIRI , IKUO FUJIMORI , TAKUYA FUJIMOTO , ZENICHI IKEDA
IPC分类号: A61K31/4439 , A61K31/506 , A61P3/10 , A61K31/416 , A61P3/04 , C07D413/04 , C07D231/54
CPC分类号: C07D413/04 , C07D401/04 , C07D405/04 , C07D417/04
摘要: The present invention provides a compound having an ACC inhibitory action, which is useful as an agent for the prophylaxis or treatment of obesity, diabetes and the like, and having superior efficacy.The present invention relates to a compound represented by the formula (I): wherein each symbol is as defined in the specification, or a salt thereof.
摘要翻译: 本发明提供具有ACC抑制作用的化合物,其可用作预防或治疗肥胖症,糖尿病等并且具有优异的疗效。 本发明涉及由式(I)表示的化合物:其中每个符号如说明书中所定义,或其盐。